2-N-propyl-4-methyl-6-(1′-methylbenzimidazol-2-yl) CAS: 152628-02-9
Catalog Number | XD94285 |
Product Name | 2-N-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl) |
CAS | 152628-02-9 |
Molecular Formula | C19H20N4 |
Molecular Weight | 304.39 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
2-N-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl) is a chemical compound with a complex structure consisting of a propyl group, a methyl group, and a benzimidazole moiety. This compound has several potential applications in the fields of pharmaceuticals and medicinal chemistry.One of the key uses of 2-N-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl) is as a potential drug candidate. Benzimidazole derivatives, like the one present in this compound, have shown promising pharmacological properties, including antimicrobial, antioxidant, and anticancer activities. Researchers have been investigating the compound's potential as a therapeutic agent due to its structural features, which make it suitable for drug design.The benzimidazole moiety in 2-N-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl) is known for its ability to interact with specific molecular targets in the body, such as enzymes and receptors. This compound can be further modified to enhance its affinity, selectivity, and metabolic stability, allowing for the development of potent and targeted drugs.Another potential application of this compound lies in the field of chemotherapy. Benzimidazole derivatives have shown promising anticancer activities by interfering with cellular processes involved in tumor growth and progression. The presence of a propyl group in this compound may enhance its ability to penetrate cell membranes and target specific cancer cells. Further research is necessary to evaluate its efficacy and potential side effects compared to existing anticancer drugs.Additionally, 2-N-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl) can be explored as a potential antimicrobial agent. Benzimidazole derivatives have demonstrated activity against various microorganisms, including bacteria and fungi. The compound's unique structure may allow for targeted interactions with specific microbial targets, making it a promising candidate for the development of new antimicrobial drugs.It is important to note that the application of 2-N-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl) in pharmaceuticals and medicinal chemistry is still under investigation. Further studies, including preclinical and clinical trials, are required to evaluate its safety, efficacy, and potential application in various disease conditions.In conclusion, 2-N-propyl-4-methyl-6-(1'-methylbenzimidazol-2-yl) is a compound with potential applications in the fields of pharmaceuticals and medicinal chemistry. Its unique structure, including a propyl group and a benzimidazole moiety, makes it suitable for drug design and development. Further research is needed to fully understand its pharmacological properties, toxicity profile, and therapeutic potential in the treatment of diseases such as cancer and microbial infections.